NEW DELHI, Dec 28: Pharmaceuticals firm Granules India Ltd on Tuesday said it has received approval from the US health regulator for its generic Prazosin Hydrochloride capsules used for the treatment of high blood pressure. The US Food & Drug Administration (USFDA) granted approval to the abbreviated new drug application (ANDA) filed by Granules Pharmaceuticals, Inc (GPI) — a wholly owned foreign subsidiary of the company — for Prazosin Hydrochloride capsules, of strengths 1mg, 2mg and 5mg, Granules India Limited […]
Related Keywords
India ,Priyanka Chigurupati ,Pfizer Inc ,Granules India ,Granules Pharmaceuticals Inc ,Us Food Drug Administration ,Granules India Ltd On ,Granules India Ltd ,Prazosin Hydrochloride ,Drug Administration ,Granules Pharmaceuticals ,Granules India Limited ,Director Priyanka Chigurupati ,
comparemela.com © 2020. All Rights Reserved.